INDUSTRY ACADEMIC COOPERATION FOUNDATION; HALLYM UNIVERSITY
发明人:
CHOI, SU YOUNG,최수영,PARK, JIN SEO,박진서,UM, WON SIK,음원식,KIM, DAE WON,김대원,JANG, SANG HO,장상호,KIM, HYOUNG CHUN,김형춘,HWANG, IN KOO,황인구,SHIN, EUN JOO,신은주,YOO, DAE YOUNG,유대영
申请号：
KR1020120097718
公开号：
KR1020140030934A
申请日:
2012.09.04
申请国别(地区):
KR
年份:
2014
代理人:
摘要：
The present invention relates to a pharmaceutical composition comprising peroxiredoxin 2 fusion protein in which a protein transport domain is covalently bonded to at least one among a N-terminal and a C-terminal of peroxiredoxin 2 protein for preventing and treating ischemic damages. The protein transport domain is either HIV-Tat peptide or PEP-1 peptide.COPYRIGHT KIPO 2014본 발명은 퍼옥시레독신 2 단백질의 N 말단 및 C 말단 중 어느 한 곳 이상에 단백질 수송도메인이 공유결합된 퍼옥시레독신 2 융합단백질을 함유하는 뇌 허혈손상 예방 및 치료용 약학 조성물에 관한 것이다.
